{
  "id": "multiple-sclerosis-000970-701bbe69ddc97648",
  "slug": "multiple-sclerosis",
  "title": "multiple sclerosis",
  "qid": "Q8277",
  "lead": "Multiple sclerosis (MS) is a chronic and neurodegenerative autoimmune disease in which the immune system attacks myelin, the insulating cover of nerve cells, causing damage to the central nervous system. This impairs the nervous system's ability to transmit signals. Symptoms include double vision, vision loss, eye pain, muscle weakness, loss of coordination, as well as cognitive issues like problems with memory. MS may be a rare complication of an Epstein-Barr virus (EBV) infection. Genetics and environmental factors like exposure to sunlight also impact the risk of MS. MS can be diagnosed based on symptoms, MRI scans, and sometimes a lumbar puncture to investigate spinal fluid. There is no cure for MS. Current treatments aim to manage symptoms during acute flares and prevent further attacks with disease-modifying therapies. With effective treatment, it is possible to reduce attacks strongly, but the disease progress is not fully stopped. In addition, symptoms of MS like balance issues can be managed with drugs and with non-drug treatments (e.g. physical therapy). On average, life expectancy is slightly lower than normal. In 2024, about 3.1 million people were affected by MS globally, with rates much higher further from the equator. The disease usually begins between the ages of 20 and 40 and is almost three times more common in women than in men.…",
  "body": "Multiple sclerosis (MS) is a chronic and neurodegenerative autoimmune disease in which the immune system attacks myelin, the insulating cover of nerve cells, causing damage to the central nervous system. This impairs the nervous system's ability to transmit signals. Symptoms include double vision, vision loss, eye pain, muscle weakness, loss of coordination, as well as cognitive issues like problems with memory. MS may be a rare complication of an Epstein-Barr virus (EBV) infection. Genetics and environmental factors like exposure to sunlight also impact the risk of MS. MS can be diagnosed based on symptoms, MRI scans, and sometimes a lumbar puncture to investigate spinal fluid. There is no cure for MS. Current treatments aim to manage symptoms during acute flares and prevent further attacks with disease-modifying therapies. With effective treatment, it is possible to reduce attacks strongly, but the disease progress is not fully stopped. In addition, symptoms of MS like balance issues can be managed with drugs and with non-drug treatments (e.g. physical therapy). On average, life expectancy is slightly lower than normal. In 2024, about 3.1 million people were affected by MS globally, with rates much higher further from the equator. The disease usually begins between the ages of 20 and 40 and is almost three times more common in women than in men. MS was first described in 1868 by French neurologist Jean-Martin Charcot. ===Epstein-Barr virus=== The Epstein-Barr virus (EBV) infects about 90 to 95% of adults and can cause infectious mononucleosis. A study of more than 10 million US military members compared 801 people who developed MS to 1,566 matched controls who did not. The study found a 32-fold increased risk of MS development following EBV infection. It did not find an increased risk after infection with other viruses, including the similar cytomegalovirus. These findings strongly suggest that EBV is necessary for MS onset, although EBV alone may be insufficient to cause it. The nuclear antigen of EBV, which is the most consistent marker of EBV infection across all strains, has been identified as a direct source of autoreactivity in the human body. These antigens appear more likely to promote autoimmunity in vitamin D deficient persons. The EBV protein EBNA1 shares similarities with three human proteins, including the brain protein GlialCAM. Because of molecular mimicry, the immune system in MS mistakenly may attack these proteins. Two are part of the nervous system, while the third is a \"guardian molecule\" which protects the body against autoimmunity. ===MS fatigue=== The mechanisms causing MS fatigue are not well understood. MS fatigue can be affected by body heat. Fatigability, defined as \"decline in physical performance over time\", correlates with perceived fatigue, but the limited correlation suggests they are distinct constructs and warrant independent assessment in clinical studies. ===McDonald criteria=== The McDonald criteria, which focus on clinical, laboratory, and radiologic evidence of lesions at different times and in different areas, is the most commonly used method of diagnosis. The 2024 McDonald criteria states that patients with multiple sclerosis should have lesions which are disseminated in space (DIS) and, in many instances, disseminated in time (DIT), i.e. lesions which have appeared in different areas in the brain and at different times. To show DIS, lesions typically need to be present in two out of five locations: spinal cord, optic nerve and three specific locations in the brain. These lesions can be detected on MRI. The optic nerve lesions can be detected with other tests too, which might be more wide available globally than MRI. For disease that has progressed over a period of 12 months or more, two spinal cord lesions are enough. DIT can shown in repeat MRIs, among other methods. To reduce delays in diagnosis, DIS is no longer required for a diagnosis of MS. Alternatively, DIS can be combined with specific MRI findings such as the central vein sign to diagnose MS. Finally, DIS can be combined with specific tests of the cerebro-spinal fluid. , no single test (including biopsy) can provide a definitive diagnosis. ===MRI=== Magnetic resonance imaging (MRI) of the brain and spine may show areas of demyelination (lesions or plaques). Gadolinium can be administered intravenously as a contrast agent to highlight active plaques, and by elimination, demonstrate the existence of historical lesions not associated with symptoms at the moment of the evaluation. The central vein sign, which shows as a dark line in the MRI through the bright white lesion, can help verify that the lesions are due to MS. Active MS lesions can have an inactive centre surrounded by microglia which contain iron. In specific MRI scans, these can be visible as paramagnetic rim lesions, which are another way to show that the lesions are likely due to MS. ===Cerebrospinal fluid (lumbar puncture)=== Testing of cerebrospinal fluid obtained from a lumbar puncture can provide evidence of chronic inflammation in the central nervous system. Two different biomarkers can show this inflammation with similar accuracy: Oligoclonal bands of IgG Kappa free-light chain (kFLC) concentrations The measurement of oligoclonal bands requires specialists labs; it is easier to measure kFLC. These two biomarkers are not only elevated in MS, but also to a lesser extent in other diseases including NMOSD. They can be used instead of dissemination in time to diagnose MS where dissemination in space is demonstrated. Radiologically isolated syndrome CIS is a first episode of MS signs and symptoms, followed by a full or almost full recovery. To be classified as CIS, the attack must last at least a full day and be due to demyelination or inflammation of the central nervous system. Individuals with CIS can in some cases be diagnosed directly with MS, if they meet more strict criteria compared to people with a history of attacks. Radiologically isolated syndrome is diagnosed when an MRI for an unrelated issue shows MS-like lesions. Similarly, people can be diagnosed with MS if they meet more strict criteria. RRMS is characterized by unpredictable relapses followed by periods of weeks to years of relative quiet (remission). Deficits that occur during attacks may either resolve fully or leave some problems. In between attacks, there is often silent progression of the disease (progression independent of relapse activity). RRMS describes the initial course of 85% of individuals with MS. RRMS can sometimes develop into SPMS, as attack frequency declines and there is clear worsening between attacks. In practical terms, the diagnosis of SPMS is typically only made in people with a minimum amount of disability. Occasional relapses and minor remissions may appear. Less frequently, MS starts as PPMS, which is characterised by a progressive worsening in the absence of attacks, from disease onset. Symptoms may become slightly less severe temporarily. ===Etymology=== The name \"multiple sclerosis\" is short for multiple cerebro-spinal sclerosis, which refers to the numerous glial scars (or sclerae – essentially plaques or lesions) that develop on the white matter of the brain and spinal cord.",
  "categories": [
    "104341943",
    "106674261",
    "109365457",
    "126254978",
    "22899191",
    "22985424",
    "23118434",
    "23603337",
    "26863021",
    "28269686",
    "30054330",
    "30525120",
    "40979899",
    "41770729",
    "64487775",
    "68328988",
    "86595638",
    "89814540"
  ],
  "license": "CC BY-SA 4.0",
  "source_uri": "https://en.wikipedia.org/w/index.php?oldid=1378903018",
  "content_hash": "701bbe69ddc97648e85cdec622fb465e060e276a71b45dc1652c0592d3cc66b9",
  "created_at": 1792308279.3737364,
  "updated_at": 1791312670.0,
  "claims": [
    {
      "id": 31548132,
      "subject_qid": "",
      "subject_slug": "multiple-sclerosis",
      "predicate": "members",
      "object_text": "801 people",
      "object_num": 801.0,
      "object_unit": "people",
      "polarity": -1,
      "qualifier": "",
      "source_uri": "https://en.wikipedia.org/w/index.php?oldid=1378903018",
      "source_name": "Wikipedia",
      "source_tier": 3,
      "retrieved_at": 1792507306.845776,
      "confidence": 0.95,
      "article_slug": "multiple-sclerosis",
      "span_start": 61,
      "span_end": 71
    }
  ],
  "contradictions": [],
  "confidence": 0.95,
  "csl": {
    "id": "multiple-sclerosis-000970-701bbe69ddc97648",
    "type": "webpage",
    "title": "multiple sclerosis",
    "author": [
      {
        "family": "Anticloud FZ LLE",
        "literal": "Anticloud FZ LLE"
      }
    ],
    "container-title": "encyclopegia.org",
    "publisher": "Anticloud FZ LLE",
    "publisher-place": "Dubai, United Arab Emirates",
    "URL": "https://encyclopegia.org/a/multiple-sclerosis",
    "issued": {
      "date-parts": [
        [
          2026,
          10,
          18
        ]
      ]
    },
    "accessed": {
      "date-parts": [
        [
          2026,
          11,
          20
        ]
      ]
    },
    "license": "CC BY-SA 4.0",
    "DOI": "eo1:multiple-sclerosis-000970-701bbe69ddc97648",
    "isBasedOn": "https://en.wikipedia.org/w/index.php?oldid=1378903018",
    "note": "Immutable snapshot multiple-sclerosis-000970-701bbe69ddc97648, content root 701bbe69ddc97648…"
  }
}